Integrated Filing — IndAS



General information about company

Scrip Code 530019
NSE Symbol JUBLPHARMA
MSEI Symbol NOTLISTED
ISIN INE700A01033
Name of company JUBILANT PHARMOVA LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 22-05-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 24-04-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Pharma
Start date and time of board meeting 22-05-2026   11:30:00
End date and time of board meeting 22-05-2026   14:10:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 06-02-2026
Indicate Company website link for updated RPT policy of the Company https://www.jubilantpharmova.com/investors/corporate-governance/policies-and-codes/policy-on-rpts
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
No such disclosure during the tenure



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 7,030.00 26,350.00
Other income 50.00 240.00
Total income 7,080.00 26,590.00
2 Expenses
(a) Cost of materials consumed 0.00 0.00
(b) Purchases of stock-in-trade 0.00 0.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 0.00 0.00
(d) Employee benefit expense 2,480.00 10,380.00
(e) Finance costs 90.00 730.00
(f) Depreciation, depletion and amortisation expense 130.00 600.00
(f) Other Expenses
1 Other Expenses 3,100.00 11,090.00
Total other expenses 3,100.00 11,090.00
Total expenses 5,800.00 22,800.00
3 Total profit before exceptional items and tax 1,280.00 3,790.00
4 Exceptional items (870.00) (870.00)
5 Total profit before tax 410.00 2,920.00
6 Tax expense
7 Current tax 20.00 460.00
8 Deferred tax (5,330.00) 470.00
9 Total tax expenses (5,310.00) 930.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 5,720.00 1,990.00
12 Profit (loss) from discontinued operations before tax 0.00 430.00
13 Tax expense of discontinued operations 0.00 (3,900.00)
14 Net profit (loss) from discontinued operation after tax 0.00 4,330.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 5,720.00 6,320.00
17 Other comprehensive income net of taxes (10.00) (90.00)
18 Total Comprehensive Income for the period 5,710.00 6,230.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 1,590.00 1,590.00
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve 2,29,640.00
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 3.59 1.25
Diluted earnings (loss) per share from continuing operations 3.59 1.25
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 2.72
Diluted earnings (loss) per share from discontinued operations 0 2.72
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 3.59 3.97
Diluted earnings (loss) per share from continuing and discontinued operations 3.59 3.97
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 31-03-2026
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 9,540.00
Capital work-in-progress 560.00
Investment property 0.00
Goodwill 0.00
Other intangible assets 250.00
Intangible assets under development 590.00
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments 2,17,600.00
Trade receivables, non-current
Loans, non-current 0.00
Other non-current financial assets
1 Other non-current financial assets 810.00
Total of other non-current financial assets 810.00
Total non-current financial assets 2,18,410.00
Deferred tax assets (net) 4,550.00
Other non-current assets
1 Other non-current assets 430.00
2 Income Tax assets (net) 2,050.00
3 Right of use asset 1,800.00
Total of other non-current assets 4,280.00
Total non-current assets 2,38,180.00
2 Current assets
Inventories 0.00
Current financial asset
Current investments 0.00
Trade receivables, current 2,380.00
Cash and cash equivalents 1,030.00
Bank balance other than cash and cash equivalents 0.00
Loans, current 10.00
Other current financial assets
Total of other current financial assets 1,670.00
Total current financial assets 5,090.00
Current tax assets (net)
Other current assets
Total of other current assets
Total current assets 5,090.00
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 2,43,270.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 1,590.00
Other equity 2,29,640.00
Total equity attributable to owners of parent 2,31,230.00
Non controlling interest
Total equity 2,31,230.00
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 5,000.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities
1 Lease Liabilities 150.00
Total of other non-current financial liabilities 150.00
Total non-current financial liabilities 5,150.00
Provisions, non-current 1,220.00
Deferred tax liabilities (net)
Deferred government grants, Non-current
Other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities 6,370.00
Current liabilities
Current financial liabilities
Borrowings, current 0.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 60.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 810.00
Total Trade payable 870.00
Other current financial liabilities
1 Lease Liablities 120.00
2 Other current financial liabilities 2,260.00
Total of other current financial liabilities 2,380.00
Total current financial liabilities 3,250.00
Other current liabilities 620.00
1 Other current liabilities 620.00
Total of other current liabilities 620.00
Provisions, current 530.00
Current tax liabilities (Net) 1,270.00
Deferred government grants, Current 0.00
Total current liabilities 5,670.00
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 12,040.00
Total equity and liabilites 2,43,270.00
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-01-2026 01-04-2025
Date of end of reporting period 31-03-2026 31-03-2026
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Items that will not be reclassified to profit and loss 10.00 (120.00)
Total Amount of items that will not be reclassified to profit and loss 10.00 (120.00)
2 Income tax relating to items that will not be reclassified to profit or loss 20.00 (30.00)
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income (10.00) (90.00)



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 31-03-2026
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 2,920.00
Adjustments for reconcile profit (loss)
Adjustments for finance costs 1,260.00
Adjustments for decrease (increase) in inventories (3,450.00)
Adjustments for decrease (increase) in trade receivables, current 7,170.00
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets 0.00
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current (1,270.00)
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current (3,190.00)
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 3,050.00
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 2,570.00
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 0.00
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 0.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains (70.00)
Adjustments for dividend income 0.00
Adjustments for interest income 90.00
Adjustments for share-based payments 150.00
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 430.00
Other adjustments for non-cash items (410.00)
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) 6,150.00
Net cash flows from (used in) operations 9,070.00
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 580.00
Other inflows (outflows) of cash 870.00
Net cash flows from (used in) operating activities 9,360.00
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 8,000.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 0.00
Purchase of property, plant and equipment 1,950.00
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 100.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (2,750.00)
Net cash flows from (used in) investing activities 3,400.00
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 7,040.00
Repayments of borrowings 10,150.00
Payments of lease liabilities 570.00
Dividends paid 7,980.00
Interest paid 1,330.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities (12,990.00)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (230.00)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents (230.00)
Cash and cash equivalents cash flow statement at beginning of period 1,260.00
Cash and cash equivalents cash flow statement at end of period 1,030.00





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 Walker Chandiok & Co LLP Yes 31-05-2028


Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Drug Discovery and Development Solutions Limited Jubilant Therapeutics Inc. Subsidiary Any other transaction Loan Receivable None 0.00 6,215.50 8,961.90
2 Drug Discovery and Development Solutions Limited Jubilant Therapeutics Inc. Subsidiary Any other transaction Interest Receivable None 0.00 835.70 372.10
3 Jubilant Biosys Innovative Research Services Pte Limited Drug Discovery and Development Solutions Limited Fellow subsidiary Any other transaction Loan Receivable None 0.00 2,663.80 2,845.10
4 Jubilant Biosys Innovative Research Services Pte Limited Drug Discovery and Development Solutions Limited Fellow subsidiary Any other transaction Interest Receivable None 0.00 496.10 416.10
5 Jubilant Biosys Limited Jubilant Biosys Innovative Research Services Pte Limited Subsidiary Any other transaction Loan Receivable None 0.00 2,663.80 2,845.10
6 Jubilant Biosys Limited Jubilant Biosys Innovative Research Services Pte Limited Subsidiary Any other transaction Interest Receivable None 0.00 408.60 520.60
7 Jubilant Biosys Limited Jubilant Cadista Pharmaceuticals Inc. Subsidiary Any other transaction Trade payable None 0.00 9.60 0.00
8 Jubilant Biosys Limited Jubilant Discovery Services LLC Fellow subsidiary Any other transaction Other Receivable None 0.00 7.00 58.50
9 Jubilant Biosys Limited Jubilant Discovery Services LLC Fellow subsidiary Any other transaction Trade payable None 0.00 714.30 1,386.80
10 Jubilant Biosys Limited Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 10.10 0.00
11 Jubilant Biosys Limited Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Trade payable None 0.00 0.00 33.00
12 Jubilant Biosys Limited Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Trade Receivable None 0.00 57.80 0.00
13 Jubilant Biosys Limited Jubilant Epicore LLC Fellow subsidiary Any other transaction Trade Receivable None 0.00 163.10 27.20
14 Jubilant Biosys Limited Jubilant Epipad LLC Fellow subsidiary Any other transaction Trade Receivable None 0.00 19.70 20.80
15 Jubilant Biosys Limited Jubilant Episcribe LLC Fellow subsidiary Any other transaction Trade Receivable None 0.00 76.10 78.90
16 Jubilant Biosys Limited Jubilant FoodWorks Limited Enterprise in which Key management personnel are interested Any other transaction Trade payable None 0.00 0.00 31.20
17 Jubilant Biosys Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Trade payable None 0.00 399.40 597.90
18 Jubilant Biosys Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Trade Receivable None 0.00 15.90 15.90
19 Jubilant Biosys Limited Jubilant Life Sciences (Shanghai) Ltd Enterprise in which Key management personnel are interested Any other transaction Trade payable None 0.00 148.40 318.50
20 Jubilant Biosys Limited Jubilant Pharma Holdings Inc. Fellow subsidiary Any other transaction Advance from Customers None 0.00 4,830.60 1,543.00
21 Jubilant Biosys Limited Jubilant Pharma Holdings Inc. Fellow subsidiary Any other transaction Trade payable None 0.00 237.50 379.00
22 Jubilant Biosys Limited Jubilant Pharma Holdings Inc. Fellow subsidiary Any other transaction Trade Receivable None 0.00 1,510.70 0.00
23 Jubilant Biosys Limited Jubilant Therapeutics Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 28.00 0.00
24 Jubilant Biosys Limited Jubilant Therapeutics India Limited Fellow subsidiary Any other transaction Other Receivable None 0.00 8.20 22.20
25 Jubilant Biosys Limited TrialStat Solutions Inc. Step down subsidiary Any other transaction Other Receivable None 0.00 0.00 414.30
26 Jubilant Biosys Limited O2 Renewable Energy XVI Private Limited Associates Any other transaction Trade payable None 0.00 258.20 321.60
27 Jubilant Biosys Limited Jubilant Biosys France SAS Subsidiary Any other transaction Trade payable None 0.00 0.00 168.80
28 Jubilant Cadista Pharmaceuticals Inc. Jubilant Biosys Limited Fellow subsidiary Any other transaction Other Receivable None 0.00 7.10 7.60
29 Jubilant Cadista Pharmaceuticals Inc. Jubilant Biosys Limited Fellow subsidiary Any other transaction Trade payable None 0.00 716.80 1,332.20
30 Jubilant Cadista Pharmaceuticals Inc. Jubilant Business Services Limited Fellow subsidiary Any other transaction Trade payable None 0.00 17.70 18.90
31 Jubilant Cadista Pharmaceuticals Inc. Jubilant Discovery Services LLC Fellow subsidiary Any other transaction Other Receivable None 0.00 0.80 0.80
32 Jubilant Cadista Pharmaceuticals Inc. Jubilant Draximage (USA) Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 25.10 54.50
33 Jubilant Cadista Pharmaceuticals Inc. Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 1.00 1.10
34 Jubilant Cadista Pharmaceuticals Inc. Jubilant HollisterStier General Partnership Fellow subsidiary Any other transaction Other Receivable None 0.00 32.90 35.10
35 Jubilant Cadista Pharmaceuticals Inc. Jubilant Industries Inc. USA Enterprise in which Key management personnel are interested Any other transaction Other Receivable None 0.00 1.40 1.40
36 Jubilant Cadista Pharmaceuticals Inc. Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Trade payable None 0.00 10.00 17.20
37 Jubilant Cadista Pharmaceuticals Inc. Jubilant Pharma ME FZ-LLC Fellow subsidiary Any other transaction Loan Receivable None 0.00 1,065.50 1,138.00
38 Jubilant Cadista Pharmaceuticals Inc. Jubilant Pharma ME FZ-LLC Fellow subsidiary Any other transaction Interest Receivable None 0.00 47.30 76.10
39 Jubilant Cadista Pharmaceuticals Inc. Jubilant Therapeutics Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 1.80 1.90
40 Jubilant Clinsys Limited Jubilant DraxImage Limited Fellow subsidiary Any other transaction Loan Receivable None 0.00 90.50 96.00
41 Jubilant Clinsys Limited Jubilant DraxImage Limited Fellow subsidiary Any other transaction Interest Receivable None 0.00 5.10 2.30
42 Jubilant Clinsys Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Trade payable None 0.00 0.00 0.10
43 Jubilant Discovery Services LLC Drug Discovery and Development Solutions Limited Intermediate parent Any other transaction Loan Receivable None 0.00 266.40 284.50
44 Jubilant Discovery Services LLC Drug Discovery and Development Solutions Limited Intermediate parent Any other transaction Interest Receivable None 0.00 23.70 8.60
45 Jubilant Discovery Services LLC TrialStat Solutions Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 0.00 31.10
46 Jubilant Discovery Services LLC Jubilant Clinsys Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 6.20 6.60
47 Jubilant Draximage (USA) Inc. Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 146.50 87.80
48 Jubilant Draximage (USA) Inc. Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Trade Receivable None 0.00 2,003.60 6,229.10
49 Jubilant Draximage (USA) Inc. Jubilant HollisterStier Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 0.30 0.60
50 Jubilant Draximage (USA) Inc. Jubilant Therapeutics Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 284.90 411.90
51 Jubilant Draximage (USA) Inc. Draxis Pharma LLC Fellow subsidiary Any other transaction Other Receivable None 0.00 0.30 0.60
52 Jubilant DraxImage Inc. Jubilant Business Services Limited Fellow subsidiary Any other transaction Other Receivable None 0.00 60.80 64.90
53 Jubilant DraxImage Inc. Jubilant Cadista Pharmaceuticals Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 4.80 9.30
54 Jubilant DraxImage Inc. Jubilant Draximage (USA) Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 11.30 35.80
55 Jubilant DraxImage Inc. Jubilant Draximage Radiopharmacies Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 0.70 0.70
56 Jubilant DraxImage Inc. Jubilant Generics Limited Fellow subsidiary Any other transaction Other Receivable None 0.00 3.80 4.00
57 Jubilant DraxImage Inc. Jubilant HollisterStier General Partnership Fellow subsidiary Any other transaction Advance to suppliers None 0.00 10,787.20 11,355.80
58 Jubilant DraxImage Inc. Jubilant HollisterStier General Partnership Fellow subsidiary Any other transaction Other Receivable None 0.00 709.80 951.70
59 Jubilant DraxImage Inc. Jubilant HollisterStier LLC Fellow subsidiary Any other transaction Other Receivable None 0.00 350.60 434.90
60 Jubilant DraxImage Inc. Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Trade payable None 0.00 70.00 51.10
61 Jubilant DraxImage Inc. Jubilant Pharma Holdings Inc. Fellow subsidiary Any other transaction Loan Receivable None 0.00 97,671.80 1,08,111.90
62 Jubilant DraxImage Inc. Jubilant Pharma Holdings Inc. Fellow subsidiary Any other transaction Interest Receivable None 0.00 3,380.60 7,366.50
63 Jubilant DraxImage Inc. Jubilant Pharma Limited Immediate parent Any other transaction Loan Receivable None 0.00 1,58,916.40 1,69,730.90
64 Jubilant DraxImage Inc. Jubilant Pharma Limited Immediate parent Any other transaction Interest Receivable None 0.00 2,762.70 0.00
65 Jubilant DraxImage Inc. Jubilant Pharma UK Limited Fellow subsidiary Any other transaction Trade payable None 0.00 0.00 1.20
66 Jubilant DraxImage Inc. Jubilant Therapeutics Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 0.10 0.10
67 Jubilant DraxImage Inc. TrialStat Solutions Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 38.30 9.40
68 Jubilant DraxImage Inc. Draxis Pharma LLC Fellow subsidiary Any other transaction Other Receivable None 0.00 2.80 3.00
69 Jubilant DraxImage Inc. Jubilant Pharmaceutical Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 0.00 27.40
70 Jubilant Draximage Radiopharmacies Inc. Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 8.90 9.50
71 Jubilant Draximage Radiopharmacies Inc. Jubilant Pharma Holdings Inc. Immediate parent Any other transaction Loan Receivable None 0.00 3,995.70 4,267.60
72 Jubilant Draximage Radiopharmacies Inc. Jubilant Pharma Holdings Inc. Immediate parent Any other transaction Interest Receivable None 0.00 900.80 1,053.60
73 Jubilant Generics Limited Jubilant Biosys Limited Fellow subsidiary Any other transaction Other Receivable None 0.00 0.00 40.10
74 Jubilant Generics Limited Jubilant Biosys Limited Fellow subsidiary Any other transaction Trade payable None 0.00 1,254.90 1,894.90
75 Jubilant Generics Limited Jubilant Cadista Pharmaceuticals Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 562.30 966.70
76 Jubilant Generics Limited Jubilant Cadista Pharmaceuticals Inc. Fellow subsidiary Any other transaction Trade payable None 0.00 546.10 974.70
77 Jubilant Generics Limited Jubilant Cadista Pharmaceuticals Inc. Fellow subsidiary Any other transaction Trade Receivable None 0.00 2,206.10 5,367.30
78 Jubilant Generics Limited Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 27.30 8.60
79 Jubilant Generics Limited Jubilant Enpro Private Limited Enterprise in which Key management personnel are interested Any other transaction Other Receivable None 0.00 18.50 25.80
80 Jubilant Generics Limited Jubilant FoodWorks Limited Enterprise in which Key management personnel are interested Any other transaction Trade payable None 0.00 0.00 9.80
81 Jubilant Generics Limited Jubilant HollisterStier General Partnership Fellow subsidiary Any other transaction Other Receivable None 0.00 76.00 102.30
82 Jubilant Generics Limited Jubilant HollisterStier LLC Fellow subsidiary Any other transaction Other Receivable None 0.00 112.60 224.90
83 Jubilant Generics Limited Jubilant HollisterStier LLC Fellow subsidiary Any other transaction Trade payable None 0.00 37.90 79.60
84 Jubilant Generics Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Other Receivable None 0.00 0.50 0.90
85 Jubilant Generics Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Trade payable None 0.00 180.00 317.10
86 Jubilant Generics Limited Jubilant Pharma Australia Pty Limited Fellow subsidiary Any other transaction Trade payable None 0.00 14.50 22.80
87 Jubilant Generics Limited Jubilant Pharma Holdings Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 4.50 4.80
88 Jubilant Generics Limited Jubilant Pharma Limited Immediate parent Any other transaction Other Receivable None 0.00 2.50 0.00
89 Jubilant Generics Limited Jubilant Pharma Limited Immediate parent Any other transaction Trade payable None 0.00 1,854.80 1,981.00
90 Jubilant Generics Limited Jubilant Pharma ME FZ-LLC Fellow subsidiary Any other transaction Trade Receivable None 0.00 407.00 321.80
91 Jubilant Generics Limited Jubilant Pharma SA (PTY) Limited Fellow subsidiary Any other transaction Trade Receivable None 0.00 483.10 274.80
92 Jubilant Generics Limited Jubilant Pharma UK Limited Fellow subsidiary Any other transaction Trade Receivable None 0.00 4,436.00 2,193.70
93 Jubilant Generics Limited Jubilant Pharmaceuticals NV Step down subsidiary Any other transaction Trade payable None 0.00 23.10 194.30
94 Jubilant Generics Limited Jubilant Therapeutics India Limited Fellow subsidiary Any other transaction Other Receivable None 0.00 0.10 0.00
95 Jubilant Generics Limited PSI Supply NV Step down subsidiary Any other transaction Trade Receivable None 0.00 365.30 509.60
96 Jubilant HollisterStier General Partnership Jubilant Business Services Limited Fellow subsidiary Any other transaction Trade Receivable None 0.00 10.20 0.00
97 Jubilant HollisterStier General Partnership Jubilant Cadista Pharmaceuticals Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 43.30 48.20
98 Jubilant HollisterStier General Partnership Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 540.80 1,202.80
99 Jubilant HollisterStier General Partnership Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Trade Receivable None 0.00 1.30 273.40
100 Jubilant HollisterStier General Partnership Jubilant HollisterStier Inc. Immediate parent Any other transaction Other Receivable None 0.00 13.00 10.60
101 Jubilant HollisterStier General Partnership Jubilant HollisterStier Inc. Immediate parent Any other transaction Trade payable None 0.00 0.40 0.40
102 Jubilant HollisterStier General Partnership Jubilant HollisterStier LLC Fellow subsidiary Any other transaction Other Receivable None 0.00 0.00 228.50
103 Jubilant HollisterStier General Partnership Jubilant HollisterStier LLC Fellow subsidiary Any other transaction Trade Receivable None 0.00 80.80 135.10
104 Jubilant HollisterStier General Partnership Jubilant HollisterStier LLC Fellow subsidiary Inter-corporate deposit None 0.00 6,215.60 6,638.60
105 Jubilant HollisterStier General Partnership Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Trade payable None 0.00 146.40 180.80
106 Jubilant HollisterStier General Partnership Jubilant Pharma Holdings Inc. Intermediate parent Any other transaction Other Receivable None 0.00 4.20 4.50
107 Jubilant HollisterStier General Partnership Draxis Pharma LLC Fellow subsidiary Any other transaction Other Receivable None 0.00 1.40 1.50
108 Jubilant HollisterStier LLC Jubilant Biosys Limited Fellow subsidiary Any other transaction Other Receivable None 0.00 39.60 43.60
109 Jubilant HollisterStier LLC Jubilant Cadista Pharmaceuticals Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 334.00 373.90
110 Jubilant HollisterStier LLC Jubilant Discovery Services LLC Fellow subsidiary Any other transaction Other Receivable None 0.00 35.60 170.60
111 Jubilant HollisterStier LLC Jubilant Draximage (USA) Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 606.30 1,130.20
112 Jubilant HollisterStier LLC Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 60.80 7.50
113 Jubilant HollisterStier LLC Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Trade payable None 0.00 30.60 90.10
114 Jubilant HollisterStier LLC Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Trade Receivable None 0.00 1,284.90 1,360.70
115 Jubilant HollisterStier LLC Jubilant HollisterStier General Partnership Fellow subsidiary Any other transaction Other Receivable None 0.00 372.90 685.60
116 Jubilant HollisterStier LLC Jubilant HollisterStier General Partnership Fellow subsidiary Any other transaction Trade Receivable None 0.00 3.00 74.60
117 Jubilant HollisterStier LLC Jubilant HollisterStier General Partnership Fellow subsidiary Any other transaction Interest Receivable None 0.00 0.00 162.20
118 Jubilant HollisterStier LLC Jubilant HollisterStier Inc. Fellow subsidiary Any other transaction Loan Receivable None 0.00 0.00 17,544.60
119 Jubilant HollisterStier LLC Jubilant HollisterStier Inc. Fellow subsidiary Any other transaction Interest Receivable None 0.00 0.00 228.00
120 Jubilant HollisterStier LLC Jubilant Industries Inc. USA Enterprise in which Key management personnel are interested Any other transaction Other Receivable None 0.00 134.90 147.90
121 Jubilant HollisterStier LLC Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Trade payable None 0.00 191.90 310.60
122 Jubilant HollisterStier LLC Jubilant Pharma Holdings Inc. Immediate parent Any other transaction Other Receivable None 0.00 17,793.30 9,593.60
123 Jubilant HollisterStier LLC Jubilant Pharma Holdings Inc. Immediate parent Any other transaction Trade payable None 0.00 3,703.60 21,722.30
124 Jubilant HollisterStier LLC Jubilant Therapeutics Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 394.80 514.20
125 Jubilant HollisterStier LLC Jubilant Clinsys Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 25.30 27.10
126 Jubilant HollisterStier LLC Draxis Pharma LLC Fellow subsidiary Any other transaction Other Receivable None 0.00 1.30 1.40
127 Jubilant HollisterStier LLC Jubilant Ingrevia (USA) Inc. Enterprise in which Key management personnel are interested Any other transaction Other Receivable None 0.00 20.90 4.80
128 Jubilant Innovation (USA) Inc. Drug Discovery and Development Solutions Limited Immediate parent Any other transaction Loan Receivable None 0.00 1,154.30 1,707.00
129 Jubilant Innovation (USA) Inc. Drug Discovery and Development Solutions Limited Immediate parent Any other transaction Interest Receivable None 0.00 102.80 38.70
130 Jubilant Pharma Holdings Inc. Drug Discovery and Development Solutions Limited Fellow subsidiary Any other transaction Loan Receivable None 0.00 33,492.50 39,375.50
131 Jubilant Pharma Holdings Inc. Drug Discovery and Development Solutions Limited Fellow subsidiary Any other transaction Interest Receivable None 0.00 1,591.30 1,184.80
132 Jubilant Pharma Holdings Inc. Jubilant Biosys Limited Fellow subsidiary Any other transaction Other Receivable None 0.00 58.70 174.30
133 Jubilant Pharma Holdings Inc. Jubilant Cadista Pharmaceuticals Inc. Subsidiary Any other transaction Other Receivable None 0.00 1,817.60 6,912.80
134 Jubilant Pharma Holdings Inc. Jubilant Cadista Pharmaceuticals Inc. Subsidiary Any other transaction Trade payable None 0.00 366.70 550.20
135 Jubilant Pharma Holdings Inc. Jubilant Discovery Services LLC Fellow subsidiary Any other transaction Other Receivable None 0.00 27.20 13.80
136 Jubilant Pharma Holdings Inc. Jubilant Draximage (USA) Inc. Subsidiary Any other transaction Other Receivable None 0.00 19.90 522.70
137 Jubilant Pharma Holdings Inc. Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 256.40 471.00
138 Jubilant Pharma Holdings Inc. Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Trade payable None 0.00 697.30 409.60
139 Jubilant Pharma Holdings Inc. Jubilant Draximage Radiopharmacies Inc. Subsidiary Any other transaction Other Receivable None 0.00 177.90 203.80
140 Jubilant Pharma Holdings Inc. Jubilant Generics Limited Fellow subsidiary Any other transaction Other Receivable None 0.00 192.60 273.90
141 Jubilant Pharma Holdings Inc. Jubilant HollisterStier General Partnership Step down subsidiary Any other transaction Other Receivable None 0.00 641.70 622.80
142 Jubilant Pharma Holdings Inc. Jubilant HollisterStier Inc. Subsidiary Any other transaction Other Receivable None 0.00 62.10 68.20
143 Jubilant Pharma Holdings Inc. Jubilant Industries Inc. USA Enterprise in which Key management personnel are interested Any other transaction Other Receivable None 0.00 21.70 49.40
144 Jubilant Pharma Holdings Inc. Jubilant Pharma Limited Immediate parent Any other transaction Loan Receivable None 0.00 2,54,301.70 2,85,832.70
145 Jubilant Pharma Holdings Inc. Jubilant Pharma Limited Immediate parent Any other transaction Interest Receivable None 0.00 3,979.90 10.70
146 Jubilant Pharma Holdings Inc. Jubilant Therapeutics Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 17.90 31.10
147 Jubilant Pharma Holdings Inc. Jubilant Innovation (USA) Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 10.20 4.50
148 Jubilant Pharma Holdings Inc. Jubilant Clinsys Inc. Subsidiary Any other transaction Other Receivable None 0.00 14.50 16.90
149 Jubilant Pharma Holdings Inc. Jubilant Ingrevia (USA) Inc. Enterprise in which Key management personnel are interested Any other transaction Other Receivable None 0.00 497.80 510.70
150 Jubilant Pharma Limited Jubilant Cadista Pharmaceuticals Inc. Intermediate parent Any other transaction Other Receivable None 0.00 766.50 818.70
151 Jubilant Pharma Limited Jubilant DraxImage Inc. Subsidiary Any other transaction Other Receivable None 0.00 194.10 519.20
152 Jubilant Pharma Limited Jubilant Pharma Australia Pty Limited Subsidiary Any other transaction Other Receivable None 0.00 22.30 24.70
153 Jubilant Pharma Limited Jubilant Pharma Holdings Inc. Subsidiary Any other transaction Other Receivable None 0.00 610.40 1,171.20
154 Jubilant Pharma Limited Mr. Shyam S. Bhartia Key management personnel Any other transaction Bonus Payable None 0.00 755.80 1,618.50
155 Jubilant Pharmaceuticals NV Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Other Receivable None 0.00 199.60 208.50
156 Jubilant Pharmaceuticals NV Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Trade payable None 0.00 0.50 0.60
157 Jubilant Pharmaceuticals NV Jubilant Life Sciences NV Enterprise in which Key management personnel are interested Any other transaction Other Receivable None 0.00 2.40 2.50
158 Jubilant Pharmaceuticals NV PSI Supply NV Fellow subsidiary Any other transaction Other Receivable None 0.00 1.60 3.20
159 Jubilant Pharmaceuticals NV Jubilant Pharma NV Immediate parent Any other transaction Other Receivable None 0.00 93.20 103.90
160 Jubilant Pharmova Limited Jubilant Biosys Limited Subsidiary Any other transaction Advance from Customers None 0.00 435.20 235.70
161 Jubilant Pharmova Limited Jubilant Biosys Limited Subsidiary Any other transaction Trade Receivable None 0.00 0.00 269.30
162 Jubilant Pharmova Limited Jubilant Biosys Limited Subsidiary Any other transaction Deposits payable None 0.00 100.00 100.00
163 Jubilant Pharmova Limited Jubilant Cadista Pharmaceuticals Inc. Step down subsidiary Any other transaction Trade Receivable None 0.00 0.00 239.20
164 Jubilant Pharmova Limited Jubilant Draximage (USA) Inc. Step down subsidiary Any other transaction Trade Receivable None 0.00 22.50 0.00
165 Jubilant Pharmova Limited Jubilant DraxImage Inc. Step down subsidiary Any other transaction Advance from Customers None 0.00 0.00 2.00
166 Jubilant Pharmova Limited Jubilant DraxImage Inc. Step down subsidiary Any other transaction Trade Receivable None 0.00 0.00 295.40
167 Jubilant Pharmova Limited Jubilant Employees Welfare Trust Subsidiary Any other transaction Trade Receivable None 0.00 119.80 45.90
168 Jubilant Pharmova Limited Jubilant Employees Welfare Trust Subsidiary Any other transaction Interest Payable None 0.00 317.30 63.90
169 Jubilant Pharmova Limited Jubilant Employees Welfare Trust Subsidiary Inter-corporate deposit None 0.00 5,000.00 5,000.00
170 Jubilant Pharmova Limited Jubilant Enpro Private Limited Enterprise in which Key management personnel are interested Any other transaction Trade Receivable None 0.00 53.50 15.00
171 Jubilant Pharmova Limited Jubilant First Trust Healthcare Limited Subsidiary Any other transaction Trade Receivable None 0.00 2.60 0.00
172 Jubilant Pharmova Limited Jubilant FoodWorks Limited Enterprise in which Key management personnel are interested Any other transaction Trade payable None 0.00 0.00 0.80
173 Jubilant Pharmova Limited Jubilant FoodWorks Limited Enterprise in which Key management personnel are interested Any other transaction Trade Receivable None 0.00 0.00 122.90
174 Jubilant Pharmova Limited Jubilant Generics Limited Step down subsidiary Any other transaction Trade Receivable None 0.00 49.40 278.10
175 Jubilant Pharmova Limited Jubilant HollisterStier General Partnership Step down subsidiary Any other transaction Trade Receivable None 0.00 303.80 353.80
176 Jubilant Pharmova Limited Jubilant HollisterStier LLC Step down subsidiary Any other transaction Trade Receivable None 0.00 0.00 206.00
177 Jubilant Pharmova Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Trade payable None 0.00 364.50 0.00
178 Jubilant Pharmova Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Trade Receivable None 0.00 1,346.10 348.00
179 Jubilant Pharmova Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Deposits payable None 0.00 50.00 50.00
180 Jubilant Pharmova Limited Jubilant Pharma Holdings Inc. Step down subsidiary Any other transaction Trade Receivable None 0.00 0.00 26.80
181 Jubilant Pharmova Limited Mr. Arun Seth Key management personnel Any other transaction Commission payable None 0.00 0.00 15.00
182 Jubilant Pharmova Limited Mr. Hari S. Bhartia Key management personnel Any other transaction Commission payable None 0.00 0.00 15.00
183 Jubilant Pharmova Limited Mr. Shirish G. Belapure Key management personnel Any other transaction Commission payable None 0.00 0.00 15.00
184 Jubilant Pharmova Limited Mr. Shyam S. Bhartia Key management personnel Any other transaction Commission payable None 0.00 0.00 15.00
185 Jubilant Pharmova Limited Mr. Sushil Kumar Roongta Key management personnel Any other transaction Commission payable None 0.00 0.00 15.00
186 Jubilant Pharmova Limited Mr. Vivek Mehra Key management personnel Any other transaction Commission payable None 0.00 0.00 15.00
187 Jubilant Pharmova Limited Jubilant Agri and Consumer Products Limited Enterprise in which Key management personnel are interested Any other transaction Trade Receivable None 0.00 157.80 174.70
188 Jubilant Pharmova Limited Ms. Shivpriya Nanda Key management personnel Any other transaction Commission payable None 0.00 0.00 15.00
189 Jubilant Pharmova Limited Dr. Harsh Mahajan Key management personnel Any other transaction Commission payable None 0.00 0.00 15.00
190 Jubilant Therapeutics Inc. Jubilant Epicore LLC Subsidiary Any other transaction Other Receivable None 0.00 1,004.50 1,346.10
191 Jubilant Therapeutics Inc. Jubilant Epipad LLC Subsidiary Any other transaction Other Receivable None 0.00 492.00 562.20
192 Jubilant Therapeutics Inc. Jubilant Episcribe LLC Subsidiary Any other transaction Other Receivable None 0.00 425.70 573.00
193 Jubilant Therapeutics Inc. Jubilant Prodel LLC Subsidiary Any other transaction Other Receivable None 0.00 74.20 79.20
194 Jubilant Therapeutics India Limited Jubilant Epicore LLC Associates Any other transaction Other Receivable None 0.00 3.80 0.00
195 Jubilant Therapeutics India Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Trade payable None 0.00 0.60 0.60
196 Jubilant Therapeutics India Limited Jubilant Therapeutics Inc. Associates Any other transaction Trade Receivable None 0.00 342.40 537.70
197 Jubilant Therapeutics India Limited Jubilant Therapeutics Inc. Associates Any other transaction Interest Receivable None 0.00 149.80 68.50
198 Jubilant Therapeutics India Limited TrialStat Solutions Inc. Fellow subsidiary Any other transaction Trade payable None 0.00 57.60 73.70
199 PSI Supply NV Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Other Receivable None 0.00 15.60 16.30
200 PSI Supply NV Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Trade payable None 0.00 104.30 109.00
201 PSI Supply NV Jubilant Life Sciences NV Enterprise in which Key management personnel are interested Any other transaction Other Receivable None 0.00 0.50 0.60
202 PSI Supply NV Jubilant Pharma UK Limited Fellow subsidiary Any other transaction Other Receivable None 0.00 123.60 189.00
203 PSI Supply NV Jubilant Pharmaceuticals NV Fellow subsidiary Any other transaction Other Receivable None 0.00 1,326.00 1,434.40
204 TrialStat Solutions Inc. Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Trade Receivable None 0.00 111.20 814.40
205 TrialStat Solutions Inc. Jubilant Epicore LLC Fellow subsidiary Any other transaction Trade Receivable None 0.00 135.60 164.20
206 TrialStat Solutions Inc. Jubilant Ingrevia (USA) Inc. Enterprise in which Key management personnel are interested Any other transaction Other Receivable None 0.00 13.70 15.70
207 Draxis Pharma LLC Jubilant HollisterStier Inc. Immediate parent Any other transaction Loan Receivable None 0.00 219.30 234.20
208 Jubilant Business Services Limited Jubilant HollisterStier General Partnership Fellow subsidiary Any other transaction Advance from Customers None 0.00 0.00 10.90
209 Jubilant Business Services Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Trade payable None 0.00 0.20 0.10
210 Jubilant First Trust Healthcare Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Trade payable None 0.00 0.10 0.20
211 Jubilant Employees Welfare Trust Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Trade payable None 0.00 0.10 0.20
212 Jubilant HollisterStier Inc. Jubilant HollisterStier General Partnership Subsidiary Any other transaction Loan Receivable None 0.00 0.00 17,544.50
213 Jubilant HollisterStier Inc. Jubilant HollisterStier General Partnership Subsidiary Any other transaction Interest Receivable None 0.00 0.00 224.20
214 Jubilant Biosys France SAS Jubilant Biosys Limited Immediate parent Any other transaction Trade payable None 0.00 94.00 19.60
215 Drug Discovery and Development Solutions Limited Jubilant Therapeutics Inc. Subsidiary Any other transaction Loans given 9,500.00 None 2,217.60 0.00 0.00 Loan 3.8600 6 Years Loan 3.9700 4 Years Unsecured Business Purpose
216 Drug Discovery and Development Solutions Limited Jubilant Therapeutics Inc. Subsidiary Interest received 2,500.00 None 288.70 0.00 0.00
217 Jubilant Biosys Innovative Research Services Pte Limited Drug Discovery and Development Solutions Limited Fellow subsidiary Interest received 0.00 None 117.40 0.00 0.00
218 Jubilant Biosys Limited Jubilant Bhartia Foundation Other related party Any other transaction Donation 150.00 None 55.50 0.00 0.00
219 Jubilant Biosys Limited Jubilant Biosys Innovative Research Services Pte Limited Subsidiary Interest received 300.00 None 108.50 0.00 0.00
220 Jubilant Biosys Limited Jubilant Cadista Pharmaceuticals Inc. Subsidiary Sale of goods or services 1,500.00 None 545.90 0.00 0.00
221 Jubilant Biosys Limited Jubilant Discovery Services LLC Fellow subsidiary Any other transaction Reimbursement of expenses 2,500.00 None 1,500.40 0.00 0.00
222 Jubilant Biosys Limited Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Reimbursement of expenses 100.00 None 33.00 0.00 0.00
223 Jubilant Biosys Limited Jubilant DraxImage Inc. Fellow subsidiary Sale of goods or services 100.00 None 23.90 0.00 0.00
224 Jubilant Biosys Limited Jubilant Epicore LLC Fellow subsidiary Sale of goods or services 800.00 None 30.80 0.00 0.00
225 Jubilant Biosys Limited Jubilant Epipad LLC Fellow subsidiary Sale of goods or services 500.00 None 20.20 0.00 0.00
226 Jubilant Biosys Limited Jubilant Episcribe LLC Fellow subsidiary Sale of goods or services 900.00 None 0.80 0.00 0.00
227 Jubilant Biosys Limited Jubilant FoodWorks Limited Enterprise in which Key management personnel are interested Any other transaction Reimbursement of expenses 300.00 None 85.00 0.00 0.00
228 Jubilant Biosys Limited Jubilant Generics Limited Fellow subsidiary Any other transaction Reimbursement of expenses 150.00 None 70.20 0.00 0.00
229 Jubilant Biosys Limited Jubilant Generics Limited Fellow subsidiary Sale of goods or services 2,000.00 None 1,637.30 0.00 0.00
230 Jubilant Biosys Limited Jubilant HollisterStier LLC Fellow subsidiary Any other transaction Reimbursement of expenses 100.00 None 1.40 0.00 0.00
231 Jubilant Biosys Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Lease Payments 5.00 None 0.10 0.00 0.00
232 Jubilant Biosys Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Reimbursement of expenses 1,100.00 None 586.50 0.00 0.00
233 Jubilant Biosys Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Purchase of goods or services 1,200.00 None 68.00 0.00 0.00
234 Jubilant Biosys Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Sale of goods or services 50.00 None 0.30 0.00 0.00
235 Jubilant Biosys Limited Jubilant Life Sciences (Shanghai) Ltd Enterprise in which Key management personnel are interested Any other transaction Reimbursement of expenses 400.00 None 171.10 0.00 0.00
236 Jubilant Biosys Limited Jubilant Pharma Holdings Inc. Fellow subsidiary Any other transaction Reimbursement of expenses 200.00 None 119.10 0.00 0.00
237 Jubilant Biosys Limited Jubilant Pharma Holdings Inc. Fellow subsidiary Purchase of goods or services 250.00 None 105.20 0.00 0.00
238 Jubilant Biosys Limited Jubilant Pharma Holdings Inc. Fellow subsidiary Sale of goods or services 10,000.00 None 1,967.20 0.00 0.00
239 Jubilant Biosys Limited Jubilant Therapeutics India Limited Fellow subsidiary Any other transaction Recovery of Expenses 10.00 None 7.50 0.00 0.00
240 Jubilant Biosys Limited Jubilant Therapeutics India Limited Fellow subsidiary Any other transaction Rental and other income 30.00 None 16.10 0.00 0.00
241 Jubilant Biosys Limited O2 Renewable Energy XVI Private Limited Associates Purchase of goods or services 2,400.00 None 862.80 0.00 0.00
242 Jubilant Cadista Pharmaceuticals Inc. Jubilant Draximage (USA) Inc. Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 26.40 0.00 0.00
243 Jubilant Cadista Pharmaceuticals Inc. Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 2.00 0.00 0.00
244 Jubilant Cadista Pharmaceuticals Inc. Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Reimbursement of expenses 0.00 None 6.20 0.00 0.00
245 Jubilant Cadista Pharmaceuticals Inc. Jubilant Pharma Holdings Inc. Immediate parent Any other transaction Recovery of Expenses 0.00 None 2,634.30 0.00 0.00
246 Jubilant Cadista Pharmaceuticals Inc. Jubilant Pharma ME FZ-LLC Fellow subsidiary Interest received 0.00 None 24.40 0.00 0.00
247 Jubilant Clinsys Limited Jubilant DraxImage Limited Fellow subsidiary Any other transaction Loans given 0.00 None 5.50 0.00 0.00 Loan 6.0400 1 Year Unsecured Business Purpose
248 Jubilant Clinsys Limited Jubilant DraxImage Limited Fellow subsidiary Interest received 0.00 None 2.90 0.00 0.00
249 Jubilant Clinsys Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Lease Payments 1.00 None 0.10 0.00 0.00
250 Jubilant Discovery Services LLC Drug Discovery and Development Solutions Limited Intermediate parent Interest received 0.00 None 4.80 0.00 0.00
251 Jubilant Discovery Services LLC TrialStat Solutions Inc. Fellow subsidiary Any other transaction Other income 0.00 None 59.20 0.00 0.00
252 Jubilant Draximage (USA) Inc. Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 250.80 0.00 0.00
253 Jubilant Draximage (USA) Inc. Jubilant DraxImage Inc. Fellow subsidiary Sale of goods or services 0.00 None 7,732.70 0.00 0.00
254 Jubilant Draximage (USA) Inc. Draxis Pharma LLC Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 0.30 0.00 0.00
255 Jubilant DraxImage Inc. Jubilant Cadista Pharmaceuticals Inc. Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 3.90 0.00 0.00
256 Jubilant DraxImage Inc. Jubilant Draximage (USA) Inc. Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 22.60 0.00 0.00
257 Jubilant DraxImage Inc. Jubilant HollisterStier General Partnership Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 180.80 0.00 0.00
258 Jubilant DraxImage Inc. Jubilant HollisterStier LLC Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 111.90 0.00 0.00
259 Jubilant DraxImage Inc. Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Reimbursement of expenses 0.00 None 97.30 0.00 0.00
260 Jubilant DraxImage Inc. Jubilant Pharma Holdings Inc. Fellow subsidiary Any other transaction Loans given 0.00 None 3,941.80 0.00 0.00 Loan 7.3600 8 Years Unsecured Business purpose
261 Jubilant DraxImage Inc. Jubilant Pharma Holdings Inc. Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 82.00 0.00 0.00
262 Jubilant DraxImage Inc. Jubilant Pharma Holdings Inc. Fellow subsidiary Interest received 0.00 None 3,575.80 0.00 0.00
263 Jubilant DraxImage Inc. Jubilant Pharma Limited Immediate parent Interest received 0.00 None 2,417.20 0.00 0.00
264 Jubilant DraxImage Inc. Jubilant Pharma UK Limited Fellow subsidiary Any other transaction Reimbursement of expenses 0.00 None 1.20 0.00 0.00
265 Jubilant DraxImage Inc. TrialStat Solutions Inc. Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 15.60 0.00 0.00
266 Jubilant DraxImage Inc. Jubilant Pharmaceutical Inc. Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 26.90 0.00 0.00
267 Jubilant DraxImage Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Lease Payments 1.00 None 0.10 0.00 0.00
268 Jubilant Draximage Radiopharmacies Inc. Jubilant Pharma Holdings Inc. Immediate parent Interest received 0.00 None 87.10 0.00 0.00
269 Jubilant Generics Limited Jubilant Bhartia Foundation Other related party Any other transaction Donation 100.00 None 7.50 0.00 0.00
270 Jubilant Generics Limited Jubilant Biosys Limited Fellow subsidiary Any other transaction Other income 600.00 None 481.50 0.00 0.00
271 Jubilant Generics Limited Jubilant Biosys Limited Fellow subsidiary Sale of goods or services 150.00 None 43.80 0.00 0.00
272 Jubilant Generics Limited Jubilant Cadista Pharmaceuticals Inc. Fellow subsidiary Any other transaction Other income 800.00 None 763.10 0.00 0.00
273 Jubilant Generics Limited Jubilant Cadista Pharmaceuticals Inc. Fellow subsidiary Any other transaction Recovery of Expenses 200.00 None 3.40 0.00 0.00
274 Jubilant Generics Limited Jubilant Cadista Pharmaceuticals Inc. Fellow subsidiary Purchase of goods or services 300.00 None 223.70 0.00 0.00
275 Jubilant Generics Limited Jubilant Cadista Pharmaceuticals Inc. Fellow subsidiary Sale of goods or services 10,000.00 None 4,560.10 0.00 0.00
276 Jubilant Generics Limited Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Reimbursement of expenses 100.00 None 16.50 0.00 0.00
277 Jubilant Generics Limited Jubilant DraxImage Inc. Fellow subsidiary Sale of goods or services 100.00 None 21.90 0.00 0.00
278 Jubilant Generics Limited Jubilant Enpro Private Limited Enterprise in which Key management personnel are interested Any other transaction Reimbursement of expenses 100.00 None 1.70 0.00 0.00
279 Jubilant Generics Limited Jubilant Enpro Private Limited Enterprise in which Key management personnel are interested Sale of goods or services 100.00 None 7.70 0.00 0.00
280 Jubilant Generics Limited Jubilant FoodWorks Limited Enterprise in which Key management personnel are interested Any other transaction Reimbursement of expenses 100.00 None 30.30 0.00 0.00
281 Jubilant Generics Limited Jubilant HollisterStier General Partnership Fellow subsidiary Sale of goods or services 100.00 None 21.00 0.00 0.00
282 Jubilant Generics Limited Jubilant HollisterStier LLC Fellow subsidiary Purchase of goods or services 200.00 None 37.20 0.00 0.00
283 Jubilant Generics Limited Jubilant HollisterStier LLC Fellow subsidiary Sale of goods or services 220.00 None 104.60 0.00 0.00
284 Jubilant Generics Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Lease Payments 50.00 None 3.10 0.00 0.00
285 Jubilant Generics Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Recovery of Expenses 125.00 None 0.50 0.00 0.00
286 Jubilant Generics Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Reimbursement of expenses 450.00 None 193.80 0.00 0.00
287 Jubilant Generics Limited Jubilant Pharma Australia Pty Limited Fellow subsidiary Any other transaction Reimbursement of expenses 100.00 None 0.60 0.00 0.00
288 Jubilant Generics Limited Jubilant Pharma Australia Pty Limited Fellow subsidiary Purchase of goods or services 100.00 None 16.20 0.00 0.00
289 Jubilant Generics Limited Jubilant Pharma Holdings Inc. Fellow subsidiary Purchase of goods or services 300.00 None 64.50 0.00 0.00
290 Jubilant Generics Limited Jubilant Pharma Limited Immediate parent Any other transaction Recovery of Expenses 100.00 None 4.10 0.00 0.00
291 Jubilant Generics Limited Jubilant Pharma ME FZ-LLC Fellow subsidiary Any other transaction Other income 500.00 None 16.60 0.00 0.00
292 Jubilant Generics Limited Jubilant Pharma ME FZ-LLC Fellow subsidiary Sale of goods or services 2,000.00 None (124.20) 0.00 0.00
293 Jubilant Generics Limited Jubilant Pharma SA (PTY) Limited Fellow subsidiary Sale of goods or services 2,500.00 None (46.60) 0.00 0.00
294 Jubilant Generics Limited Jubilant Pharma UK Limited Fellow subsidiary Sale of goods or services 12,500.00 None 808.30 0.00 0.00
295 Jubilant Generics Limited Jubilant Pharmaceuticals NV Step down subsidiary Any other transaction Reimbursement of expenses 1,050.00 None 489.00 0.00 0.00
296 Jubilant Generics Limited Mr. Shirish G. Belapure Key management personnel Any other transaction Sitting fees and director fees 0.00 None 5.50 0.00 0.00
297 Jubilant Generics Limited PSI Supply NV Step down subsidiary Sale of goods or services 3,000.00 None 718.70 0.00 0.00
298 Jubilant HollisterStier General Partnership Jubilant Cadista Pharmaceuticals Inc. Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 1.90 0.00 0.00
299 Jubilant HollisterStier General Partnership Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 1,009.40 0.00 0.00
300 Jubilant HollisterStier General Partnership Jubilant DraxImage Inc. Fellow subsidiary Sale of goods or services 0.00 None 196.90 0.00 0.00
301 Jubilant HollisterStier General Partnership Jubilant HollisterStier Inc. Immediate parent Any other transaction Recovery of Expenses 0.00 None (3.00) 0.00 0.00
302 Jubilant HollisterStier General Partnership Jubilant HollisterStier LLC Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 15.10 0.00 0.00
303 Jubilant HollisterStier General Partnership Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Reimbursement of expenses 0.00 None 23.40 0.00 0.00
304 Jubilant HollisterStier LLC Jubilant Cadista Pharmaceuticals Inc. Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 16.20 0.00 0.00
305 Jubilant HollisterStier LLC Jubilant Discovery Services LLC Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 126.50 0.00 0.00
306 Jubilant HollisterStier LLC Jubilant Draximage (USA) Inc. Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 456.70 0.00 0.00
307 Jubilant HollisterStier LLC Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 8.00 0.00 0.00
308 Jubilant HollisterStier LLC Jubilant DraxImage Inc. Fellow subsidiary Sale of goods or services 0.00 None 1,481.90 0.00 0.00
309 Jubilant HollisterStier LLC Jubilant HollisterStier General Partnership Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 273.00 0.00 0.00
310 Jubilant HollisterStier LLC Jubilant HollisterStier General Partnership Fellow subsidiary Interest received 0.00 None 154.10 0.00 0.00
311 Jubilant HollisterStier LLC Jubilant HollisterStier General Partnership Fellow subsidiary Purchase of goods or services 0.00 None 45.80 0.00 0.00
312 Jubilant HollisterStier LLC Jubilant HollisterStier General Partnership Fellow subsidiary Sale of goods or services 0.00 None 68.80 0.00 0.00
313 Jubilant HollisterStier LLC Jubilant HollisterStier Inc. Fellow subsidiary Any other transaction Loans given 0.00 None 16,615.80 0.00 0.00 Loan 4.00 3 years Unsecured business purpose
314 Jubilant HollisterStier LLC Jubilant HollisterStier Inc. Fellow subsidiary Interest received 0.00 None 218.20 0.00 0.00
315 Jubilant HollisterStier LLC Jubilant Industries Inc. USA Enterprise in which Key management personnel are interested Any other transaction Recovery of Expenses 0.00 None 3.60 0.00 0.00
316 Jubilant HollisterStier LLC Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Reimbursement of expenses 0.00 None 97.30 0.00 0.00
317 Jubilant HollisterStier LLC Jubilant Pharma Holdings Inc. Immediate parent Any other transaction Recovery of Expenses 0.00 None 70.40 0.00 0.00
318 Jubilant HollisterStier LLC Jubilant Therapeutics Inc. Fellow subsidiary Any other transaction Recovery of Expenses 300.00 None 88.10 0.00 0.00
319 Jubilant HollisterStier LLC Jubilant Ingrevia (USA) Inc. Enterprise in which Key management personnel are interested Any other transaction Recovery of Expenses 0.00 None 9.00 0.00 0.00
320 Jubilant Innovation (USA) Inc. Drug Discovery and Development Solutions Limited Immediate parent Any other transaction Loans given 0.00 None 457.50 0.00 0.00 Loan 3.8600 7 Years Unsecured Business Purpose
321 Jubilant Innovation (USA) Inc. Drug Discovery and Development Solutions Limited Immediate parent Interest received 0.00 None 22.50 0.00 0.00
322 Jubilant Pharma Holdings Inc. Drug Discovery and Development Solutions Limited Fellow subsidiary Any other transaction Loans given 0.00 None 3,452.70 0.00 0.00 Loan 3.8800 6 years Unsecured Business Purpose
323 Jubilant Pharma Holdings Inc. Drug Discovery and Development Solutions Limited Fellow subsidiary Interest received 0.00 None 683.80 0.00 0.00
324 Jubilant Pharma Holdings Inc. Jubilant Cadista Pharmaceuticals Inc. Subsidiary Any other transaction Recovery of Expenses 0.00 None 150.30 0.00 0.00
325 Jubilant Pharma Holdings Inc. Jubilant Cadista Pharmaceuticals Inc. Subsidiary Sale of goods or services 0.00 None 384.80 0.00 0.00
326 Jubilant Pharma Holdings Inc. Jubilant Discovery Services LLC Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 12.50 0.00 0.00
327 Jubilant Pharma Holdings Inc. Jubilant Draximage (USA) Inc. Subsidiary Any other transaction Recovery of Expenses 0.00 None 624.90 0.00 0.00
328 Jubilant Pharma Holdings Inc. Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 3,195.70 0.00 0.00
329 Jubilant Pharma Holdings Inc. Jubilant DraxImage Inc. Fellow subsidiary Sale of goods or services 0.00 None 1,868.20 0.00 0.00
330 Jubilant Pharma Holdings Inc. Jubilant Draximage Radiopharmacies Inc. Subsidiary Any other transaction Recovery of Expenses 0.00 None 13.30 0.00 0.00
331 Jubilant Pharma Holdings Inc. Jubilant HollisterStier General Partnership Step down subsidiary Any other transaction Recovery of Expenses 0.00 None 4.80 0.00 0.00
332 Jubilant Pharma Holdings Inc. Jubilant HollisterStier General Partnership Step down subsidiary Sale of goods or services 0.00 None (66.80) 0.00 0.00
333 Jubilant Pharma Holdings Inc. Jubilant HollisterStier Inc. Subsidiary Any other transaction Recovery of Expenses 0.00 None 1.70 0.00 0.00
334 Jubilant Pharma Holdings Inc. Jubilant HollisterStier LLC Subsidiary Any other transaction Recovery of Expenses 0.00 None 14,324.80 0.00 0.00
335 Jubilant Pharma Holdings Inc. Jubilant HollisterStier LLC Subsidiary Sale of goods or services 0.00 None 2,765.00 0.00 0.00
336 Jubilant Pharma Holdings Inc. Jubilant Industries Inc. USA Enterprise in which Key management personnel are interested Any other transaction Recovery of Expenses 0.00 None 25.50 0.00 0.00
337 Jubilant Pharma Holdings Inc. Jubilant Pharma Limited Immediate parent Any other transaction Loans given 0.00 None 13,723.50 0.00 0.00 Loan 5.8800 5 years Loan 3.9300 7 years Unsecured business purpose
338 Jubilant Pharma Holdings Inc. Jubilant Pharma Limited Immediate parent Interest received 0.00 None 4,035.00 0.00 0.00
339 Jubilant Pharma Holdings Inc. Jubilant Therapeutics Inc. Fellow subsidiary Any other transaction Recovery of Expenses 100.00 None 11.30 0.00 0.00
340 Jubilant Pharma Holdings Inc. Jubilant Innovation (USA) Inc. Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 1.40 0.00 0.00
341 Jubilant Pharma Holdings Inc. Jubilant Clinsys Inc. Subsidiary Any other transaction Recovery of Expenses 0.00 None 1.40 0.00 0.00
342 Jubilant Pharma Holdings Inc. Jubilant Ingrevia (USA) Inc. Enterprise in which Key management personnel are interested Any other transaction Recovery of Expenses 0.00 None 101.00 0.00 0.00
343 Jubilant Pharma Holdings Inc. Jubilant Ingrevia (USA) Inc. Enterprise in which Key management personnel are interested Sale of goods or services 0.00 None 73.20 0.00 0.00
344 Jubilant Pharma Limited Jubilant DraxImage Inc. Subsidiary Sale of goods or services 0.00 None 1,113.50 0.00 0.00
345 Jubilant Pharma Limited Jubilant Pharma Holdings Inc. Subsidiary Sale of goods or services 0.00 None 1,113.50 0.00 0.00
346 Jubilant Pharma Limited Mr. Shyam S. Bhartia Key management personnel Remuneration 3,300.00 None 1,642.30 0.00 0.00
347 Jubilant Pharmaceuticals NV Jubilant Life Sciences NV Enterprise in which Key management personnel are interested Any other transaction Recovery of Expenses 60.00 None 14.80 0.00 0.00
348 Jubilant Pharmaceuticals NV PSI Supply NV Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 9.70 0.00 0.00
349 Jubilant Pharmova Limited Jubilant Bhartia Foundation Other related party Any other transaction Donation 200.00 None 53.00 0.00 0.00
350 Jubilant Pharmova Limited Jubilant Bhartia Foundation Other related party Sale of goods or services 100.00 None 16.50 0.00 0.00
351 Jubilant Pharmova Limited Jubilant Biosys Limited Subsidiary Any other transaction Recovery of Expenses 1,100.00 None 64.30 0.00 0.00
352 Jubilant Pharmova Limited Jubilant Biosys Limited Subsidiary Any other transaction Reimbursement of expenses 1,500.00 None 28.30 0.00 0.00
353 Jubilant Pharmova Limited Jubilant Biosys Limited Subsidiary Sale of goods or services 12,600.00 None 3,897.40 0.00 0.00
354 Jubilant Pharmova Limited Jubilant Cadista Pharmaceuticals Inc. Step down subsidiary Sale of goods or services 3,400.00 None 389.10 0.00 0.00
355 Jubilant Pharmova Limited Jubilant Draximage (USA) Inc. Step down subsidiary Any other transaction Recovery of Expenses 800.00 None 383.90 0.00 0.00
356 Jubilant Pharmova Limited Jubilant DraxImage Inc. Step down subsidiary Sale of goods or services 5,900.00 None 3,238.90 0.00 0.00
357 Jubilant Pharmova Limited Jubilant Employees Welfare Trust Subsidiary Any other transaction Recovery of Expenses 200.00 None 45.90 0.00 0.00
358 Jubilant Pharmova Limited Jubilant Employees Welfare Trust Subsidiary Interest paid 700.00 None 172.10 0.00 0.00
359 Jubilant Pharmova Limited Jubilant Enpro Private Limited Enterprise in which Key management personnel are interested Sale of goods or services 600.00 None 88.80 0.00 0.00
360 Jubilant Pharmova Limited Jubilant FoodWorks Limited Enterprise in which Key management personnel are interested Any other transaction Reimbursement of expenses 200.00 None 0.80 0.00 0.00
361 Jubilant Pharmova Limited Jubilant FoodWorks Limited Enterprise in which Key management personnel are interested Sale of goods or services 2,200.00 None 1,003.80 0.00 0.00
362 Jubilant Pharmova Limited Jubilant Generics Limited Step down subsidiary Any other transaction Recovery of Expenses 900.00 None (66.40) 0.00 0.00
363 Jubilant Pharmova Limited Jubilant Generics Limited Step down subsidiary Any other transaction Reimbursement of expenses 300.00 None 8.50 0.00 0.00
364 Jubilant Pharmova Limited Jubilant Generics Limited Step down subsidiary Sale of goods or services 4,800.00 None 708.10 0.00 0.00
365 Jubilant Pharmova Limited Jubilant HollisterStier General Partnership Step down subsidiary Sale of goods or services 900.00 None 34.70 0.00 0.00
366 Jubilant Pharmova Limited Jubilant HollisterStier LLC Step down subsidiary Any other transaction Recovery of Expenses 100.00 None 2.80 0.00 0.00
367 Jubilant Pharmova Limited Jubilant HollisterStier LLC Step down subsidiary Sale of goods or services 6,000.00 None 3,218.90 0.00 0.00
368 Jubilant Pharmova Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Lease Payments 400.00 None 153.40 0.00 0.00
369 Jubilant Pharmova Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Recovery of Expenses 100.00 None 18.50 0.00 0.00
370 Jubilant Pharmova Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Reimbursement of expenses 1,400.00 None 182.10 0.00 0.00
371 Jubilant Pharmova Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Purchase of goods or services 2,000.00 None (0.50) 0.00 0.00
372 Jubilant Pharmova Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Sale of goods or services 5,000.00 None 1,975.90 0.00 0.00
373 Jubilant Pharmova Limited Jubilant Pharma Holdings Inc. Step down subsidiary Any other transaction Reimbursement of expenses 300.00 None (26.00) 0.00 0.00
374 Jubilant Pharmova Limited Mr. Arun Kumar Sharma Key management personnel Remuneration 0.00 None 99.80 0.00 0.00
375 Jubilant Pharmova Limited Mr. Arun Seth Key management personnel Any other transaction Commission 0.00 None 15.00 0.00 0.00
376 Jubilant Pharmova Limited Mr. Arun Seth Key management personnel Any other transaction Sitting fees and director fees 0.00 None 7.30 0.00 0.00
377 Jubilant Pharmova Limited Mr. Arvind Chokhany Key management personnel Remuneration 0.00 None 59.10 0.00 0.00
378 Jubilant Pharmova Limited Mr. Hari S. Bhartia Key management personnel Any other transaction Commission 0.00 None 15.00 0.00 0.00
379 Jubilant Pharmova Limited Mr. Hari S. Bhartia Key management personnel Any other transaction Sitting fees and director fees 21.00 None 2.00 0.00 0.00
380 Jubilant Pharmova Limited Mr. Naresh Kapoor Key management personnel Remuneration 0.00 None 52.30 0.00 0.00
381 Jubilant Pharmova Limited Mr. Shirish G. Belapure Key management personnel Any other transaction Commission 0.00 None 15.00 0.00 0.00
382 Jubilant Pharmova Limited Mr. Shirish G. Belapure Key management personnel Any other transaction Sitting fees and director fees 0.00 None 5.30 0.00 0.00
383 Jubilant Pharmova Limited Mr. Shyam S. Bhartia Key management personnel Any other transaction Commission 0.00 None 15.00 0.00 0.00
384 Jubilant Pharmova Limited Mr. Shyam S. Bhartia Key management personnel Any other transaction Sitting fees and director fees 24.00 None 2.80 0.00 0.00
385 Jubilant Pharmova Limited Mr. Sushil Kumar Roongta Key management personnel Any other transaction Commission 0.00 None 15.00 0.00 0.00
386 Jubilant Pharmova Limited Mr. Sushil Kumar Roongta Key management personnel Any other transaction Sitting fees and director fees 0.00 None 8.00 0.00 0.00
387 Jubilant Pharmova Limited Mr. Vivek Mehra Key management personnel Any other transaction Commission 0.00 None 15.00 0.00 0.00
388 Jubilant Pharmova Limited Mr. Vivek Mehra Key management personnel Any other transaction Sitting fees and director fees 0.00 None 6.50 0.00 0.00
389 Jubilant Pharmova Limited Mr. Arjun Shanker Bhartia Key management personnel Remuneration 750.00 None 374.80 0.00 0.00
390 Jubilant Pharmova Limited Mr. Priyavrat Bhartia Key management personnel Remuneration 750.00 None 374.80 0.00 0.00
391 Jubilant Pharmova Limited Jubilant Agri and Consumer Products Limited Enterprise in which Key management personnel are interested Sale of goods or services 900.00 None 423.50 0.00 0.00
392 Jubilant Pharmova Limited Ms. Shivpriya Nanda Key management personnel Any other transaction Commission 0.00 None 15.00 0.00 0.00
393 Jubilant Pharmova Limited Ms. Shivpriya Nanda Key management personnel Any other transaction Sitting fees and director fees 0.00 None 6.50 0.00 0.00
394 Jubilant Pharmova Limited Dr. Harsh Mahajan Key management personnel Any other transaction Commission 0.00 None 15.00 0.00 0.00
395 Jubilant Pharmova Limited Dr. Harsh Mahajan Key management personnel Any other transaction Sitting fees and director fees 0.00 None 5.30 0.00 0.00
396 Jubilant Pharmova Limited Dr. Ramakrishnan Arul Key management personnel Remuneration 0.00 None (0.10) 0.00 0.00
397 Jubilant Therapeutics Inc. Drug Discovery and Development Solutions Limited Immediate parent Any other transaction Conversion of CPNs into common stock 35,998.70 None 35,998.70 0.00 0.00
398 Jubilant Therapeutics Inc. Jubilant Draximage (USA) Inc. Fellow subsidiary Any other transaction Reimbursement of expenses 300.00 None 102.60 0.00 0.00
399 Jubilant Therapeutics Inc. Jubilant Epicore LLC Subsidiary Any other transaction Recovery of Expenses 600.00 None 260.30 0.00 0.00
400 Jubilant Therapeutics Inc. Jubilant Epicore LLC Subsidiary Investment 2,600.00 None 705.50 0.00 0.00 Loan 3.9700 4 Years Investment 0 NA Unsecured Business purpose
401 Jubilant Therapeutics Inc. Jubilant Epipad LLC Subsidiary Any other transaction Recovery of Expenses 300.00 None 34.90 0.00 0.00
402 Jubilant Therapeutics Inc. Jubilant Epipad LLC Subsidiary Investment 900.00 None 70.40 0.00 0.00 Loan 3.9700 4 Years Investment 0 NA Unsecured Business purpose
403 Jubilant Therapeutics Inc. Jubilant Episcribe LLC Subsidiary Any other transaction Recovery of Expenses 300.00 None 112.30 0.00 0.00
404 Jubilant Therapeutics Inc. Jubilant Episcribe LLC Subsidiary Investment 900.00 None 66.10 0.00 0.00 Loan 3.9700 4 Years Investment 0 NA Unsecured Business purpose
405 Jubilant Therapeutics Inc. Jubilant Prodel LLC Subsidiary Investment 900.00 None 7.10 0.00 0.00 Loan 3.9700 4 Years Investment 0 NA Unsecured Business purpose
406 Jubilant Therapeutics India Limited Jubilant Bhartia Foundation Other related party Any other transaction Donation 8.00 None 3.00 0.00 0.00
407 Jubilant Therapeutics India Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Lease Payments 0.20 None 0.10 0.00 0.00
408 Jubilant Therapeutics India Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Reimbursement of expenses 2.50 None 1.10 0.00 0.00
409 Jubilant Therapeutics India Limited Jubilant Therapeutics Inc. Associates Interest received 200.00 None 96.50 0.00 0.00
410 Jubilant Therapeutics India Limited Jubilant Therapeutics Inc. Associates Sale of goods or services 900.00 None 297.30 0.00 0.00
411 PSI Supply NV Jubilant Life Sciences NV Enterprise in which Key management personnel are interested Any other transaction Recovery of Expenses 0.00 None 1.20 0.00 0.00
412 PSI Supply NV Jubilant Pharma UK Limited Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 56.10 0.00 0.00
413 PSI Supply NV Jubilant Pharma UK Limited Fellow subsidiary Sale of goods or services 0.00 None (2.80) 0.00 0.00
414 TrialStat Solutions Inc. Jubilant Biosys Limited Intermediate parent Purchase of goods or services 500.00 None 394.70 0.00 0.00
415 TrialStat Solutions Inc. Jubilant DraxImage Inc. Fellow subsidiary Sale of goods or services 0.00 None 548.20 0.00 0.00
416 TrialStat Solutions Inc. Jubilant Epicore LLC Fellow subsidiary Sale of goods or services 200.00 None 18.70 0.00 0.00
417 TrialStat Solutions Inc. Jubilant Therapeutics India Limited Fellow subsidiary Sale of goods or services 100.00 None 11.70 0.00 0.00
418 TrialStat Solutions Inc. Jubilant Ingrevia (USA) Inc. Enterprise in which Key management personnel are interested Any other transaction Recovery of Expenses 300.00 None 87.40 0.00 0.00
419 Jubilant Business Services Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Lease Payments 100.00 None 0.10 0.00 0.00
420 Jubilant First Trust Healthcare Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Lease Payments 1.00 None 0.10 0.00 0.00
421 Jubilant Employees Welfare Trust Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Lease Payments 100.00 None 0.10 0.00 0.00
422 Jubilant HollisterStier Inc. Jubilant Draximage (USA) Inc. Fellow subsidiary Any other transaction Reimbursement of expenses 0.00 None 0.30 0.00 0.00
423 Jubilant HollisterStier Inc. Jubilant HollisterStier General Partnership Subsidiary Any other transaction Loans given 0.00 None 16,615.70 0.00 0.00 Loan 4.00 3 years Loan 4.00 3 years Unsecured Business purpose
424 Jubilant HollisterStier Inc. Jubilant HollisterStier General Partnership Subsidiary Interest received 0.00 None 214.60 0.00 0.00
425 Jubilant Biosys France SAS Jubilant Biosys Limited Immediate parent Any other transaction Other income 500.00 None 165.90 0.00 0.00
426 Jubilant Biosys France SAS Jubilant Biosys Limited Immediate parent Any other transaction Reimbursement of expenses 500.00 None 74.70 0.00 0.00
Total value of transaction during the reporting period 1,84,250.60